4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial Peripheral Intravenous (IV) infusion of LMSCs - Metabolic Disease, Endothelial Dysfunction | Phase 2 | Withdrawn | Longeveron Inc. | 2023-12-01 | 2023-02-16 | |
| Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients Nitrogen Gas for Inhalation, Blood withdrawal, Nitric Oxide - Cardiovascular Diseases, Oxidative Stress | Phase 2 | Withdrawn | Massachusetts General Hospital | 2019-07-25 | 2025-12-02 | |
| Effects of Nitric Oxide on the Endothelium During Hemolysis. Nitric Oxide, Reactive Hyperemia Index, Endothelial Cells Collection - Endothelial Dysfunction, Hemolysis Intravascular | Phase 2 | Withdrawn | Massachusetts General Hospital | 2018-12-05 | 2025-12-02 | |
| Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance GHRP-3 low dose, GHRP-3 high dose, Saline - Insulin Resistance, Endothelial Dysfunction | Phase 1 / Phase 2 | Withdrawn | Tulane University Health Sciences Center | 2008-07-01 | 2021-01-08 |
Cardiovascular Diseases (2) · Hemolysis (1) · Insulin Resistance (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (2) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Nitric Oxide (2) · Biological Products (1) · Inhalation (1) · Mannitol (1) · Nitrogen (1) · Sodium Chloride (1)
Massachusetts General Hospital (2) · Longeveron Inc. (1) · Tulane University Health Sciences Center (1)
United States (2) · United Kingdom (1)
Anthony Oliva, PhD (1) · Lorenzo Berra, MD (1) · Tina K Thethi, MD, MPH (1)